Suppr超能文献

起搏器植入术后腕管综合征与淀粉样变性、心力衰竭和死亡率的关系。

Carpal Tunnel Syndrome in Patients Who Underwent Pacemaker Implantation and Relation to Amyloidosis, Heart Failure, and Mortality.

机构信息

The Heart Center, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.

The Heart Center, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.

出版信息

Am J Cardiol. 2022 Aug 15;177:121-127. doi: 10.1016/j.amjcard.2022.04.059. Epub 2022 Jun 18.

Abstract

Advances in treatment warrant earlier diagnosis of cardiac amyloidosis (CA). Common cardiac and extracardiac manifestations of CA, such as pacemaker implantation and carpal tunnel syndrome (CTS), might provide screening opportunities for CA. However the association between CTS and CA in patients undergoing pacemaker implantation has not been well studied. This study examined the association between previous CTS surgery and adverse cardiovascular outcomes in patients who underwent pacemaker implantation. Using Danish nationwide registries, we identified all patients ≥50 years who underwent first-time pacemaker implantation during 2000 to 2018, examining the association between previous CTS surgery and adverse cardiovascular outcomes 5 years after pacemaker implantation. Cumulative incidence functions and Cox proportional hazard models were used to assess the differences. Among 57,315 patients who underwent pacemaker implantation, 2.2% (n = 1,266) had previous CTS surgery. Patients in the CTS cohort were older, more often female, and had more co-morbidities than patients without CTS. The cumulative 5-year mortality was higher among patients with CTS (44.6% [41.1% to 47.9%] versus 40.2% [39.7% to 40.6%], p = 0.04). In the adjusted models, previous CTS surgery was not associated with increased 5-year mortality, but it was associated with an increased rate of hospitalization for new-onset heart failure, (hazard ratio 1.32 [1.11 to 1.57], p = 0.002) and a higher risk of amyloidosis diagnosis after pacemaker implantation (hazard ratio 7.72 [2.96 to 20.10], p <0.0001), compared with no previous CTS surgery. In patients who underwent pacemaker implantation, adjusted models showed that previous CTS surgery was associated with a higher incidence of hospitalization for new-onset heart failure and amyloidosis diagnosis after pacemaker implantation. Screening for CA may be considered in patients undergoing pacemaker implantation.

摘要

治疗进展需要更早诊断心脏淀粉样变性(CA)。CA 的常见心脏和心脏外表现,如起搏器植入和腕管综合征(CTS),可能为 CA 提供筛查机会。然而,起搏器植入患者中 CTS 与 CA 之间的关联尚未得到很好的研究。本研究检查了在接受起搏器植入的患者中,先前 CTS 手术与不良心血管结局之间的关联。使用丹麦全国性登记处,我们确定了在 2000 年至 2018 年间首次接受起搏器植入的所有年龄≥50 岁的患者,检查了起搏器植入后 5 年内先前 CTS 手术与不良心血管结局之间的关联。使用累积发生率函数和 Cox 比例风险模型来评估差异。在接受起搏器植入的 57315 名患者中,2.2%(n=1266)有先前的 CTS 手术史。CTS 组的患者年龄较大,女性更多,合并症也更多。CTS 组患者的 5 年死亡率较高(44.6%[41.1%至 47.9%]比 40.2%[39.7%至 40.6%],p=0.04)。在调整后的模型中,先前的 CTS 手术与 5 年死亡率增加无关,但与新发心力衰竭住院率增加相关(风险比 1.32[1.11 至 1.57],p=0.002),以及起搏器植入后发生淀粉样变性的风险增加(风险比 7.72[2.96 至 20.10],p<0.0001),与无先前 CTS 手术相比。在接受起搏器植入的患者中,调整后的模型显示,先前的 CTS 手术与起搏器植入后新发心力衰竭和淀粉样变性诊断的住院发生率增加相关。在接受起搏器植入的患者中,可能需要考虑筛查 CA。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验